Figure 1
Comparison of individual patient plasma biomarker concentrations across all patient groups. A total of 244 normal controls (Con), 223 patients with benign gynecological conditions (Ben), 53 patients with borderline ovarian tumours (B/L) and 222 cases of malignant epithelial ovarian cancer (Malignant) were analysed. Open circles indicate the individual values of each patient measurement shown on a log scale and horizontal lines show median concentration of each group. *: p < 0.05, compared with Con group; ^: p < 0.05 compared with Ben group (Kruskal-Wallis test followed by Dunn's multiple comparison test)